Literature DB >> 7049951

Lobar pneumonia in rats produced by clinical isolates of Klebsiella pneumoniae.

P Domenico, W G Johanson, D C Straus.   

Abstract

Transtracheal instillation of clinical isolate Klebsiella pneumoniae serotype 1 (KP1) into the lungs of rats resulted in the production of a characteristic, chronic lobar pneumonia. To further examine this phenomenon, two variants of this organism were employed in this experimental model. These variants differed markedly in capsule size, colony morphology, and in virulence, as determined by mouse lethality tests. The ability of these strains to establish a lobar pneumonia in rats correlated with the virulence of the respective organisms as monitored by intraperitoneal injection in mice. The 50% lethal doses in mice were 4.9 x 10(1) colony-forming units (CFU) for the more virulent KP1 strain (KP1-O) and 1.42 x 10(5) CFU for the less virulent variant (KP1-T). In the rat lung model, marked lung pathology was evident by day 6 with a KP1-O inoculum of 5 x 10(2) CFU, whereas KP1-T caused little or no lung pathology when delivered transtracheally at a concentration of 7 x 10(6) CFU. Two relatively nonvirulent variants of K. pneumoniae serotype 2 were also used in this rat lung model and were found not to produce a lobar pneumonia even when delivered in large doses. These results indicate that a chronic lobar pneumonia can be established in a rat model if the appropriate organism is employed and the virulence of K. pneumoniae injected intraperitoneally into mice is an excellent indicator of an organism's potential to cause lobar pneumonia in rats.

Entities:  

Mesh:

Year:  1982        PMID: 7049951      PMCID: PMC347530          DOI: 10.1128/iai.37.1.327-335.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Immunologic paralysis produced in mice by Klebsiella pneumoniae type 2 polysaccharide.

Authors:  B A BATSHON; H BAER; M F SHAFFER
Journal:  J Immunol       Date:  1963-01       Impact factor: 5.422

2.  The pathogenicity of Klebsiella pneumoniae for mice: the relationship to the quantity and rate of production of type-specific capsular polysaccharide.

Authors:  H BAER; L EHRENWORTH
Journal:  J Bacteriol       Date:  1956-11       Impact factor: 3.490

3.  Friedländer bacillus infection of the lung; with special reference to classification and pathogenesis.

Authors:  L D ERASMUS
Journal:  Q J Med       Date:  1956-10

4.  Relationship of serum beta-glucuronidase and lysozyme to pathogenesis of tularemia in immune and nonimmune rats.

Authors:  P G Canonico; M C Powanda; G L Cockerell; J B Moe
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

5.  Further studies on generation of macrophages in in vitro cultures of mouse spleen cells and its inhibition by the capsular polysaccharide of Klebsiella pneumoniae.

Authors:  T Yokochi; I Nakashima; N Kato
Journal:  Microbiol Immunol       Date:  1979       Impact factor: 1.955

6.  Effect of capsular polysaccharide of Klebsiella pneumoniae on the differentiation and functional capacity of macrophages cultured in vitro.

Authors:  T Yokochi; I Nakashima; N Kato
Journal:  Microbiol Immunol       Date:  1977-10-20       Impact factor: 1.955

7.  Microbiology of nosocomial infections.

Authors:  V Lorian; B Topf
Journal:  Arch Intern Med       Date:  1972-07

8.  Friedlander's pneumonia. A report of 11 cases and appraisal of antibiotic therapy.

Authors:  N R Hoffman; F S Preston
Journal:  Dis Chest       Date:  1968-04

9.  Nonhuman primate model for the study of respiratory Klebsiella pneumoniae infection.

Authors:  R F Berendt; G L Knutsen; M C Powanda
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

10.  Pathogenesis of respiratory Klebsiella pneumoniae infection in rats: bacteriological and histological findings and metabolic alterations.

Authors:  R F Berendt; G G Long; F B Abeles; P G Canonico; M R Elwell; M C Powanda
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

View more
  35 in total

1.  Virulence of silver-resistant mutant of Klebsiella pneumoniae in burn wound model.

Authors:  L K Gupta; R Jindal; H K Beri; S Chhibber
Journal:  Folia Microbiol (Praha)       Date:  1992       Impact factor: 2.099

2.  Isolation and characterization of Klebsiella pneumoniae unencapsulated mutants.

Authors:  V J Benedí; B Ciurana; J M Tomás
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

3.  Salicylate-enhanced exposure of Klebsiella pneumoniae subcapsular components.

Authors:  R J Salo; P Domenico; J M Tomás; D C Straus; S Merino; V J Benedí; B A Cunha
Journal:  Infection       Date:  1995 Nov-Dec       Impact factor: 3.553

4.  Recognition of bacterial surface polysaccharides by lectins of the innate immune system and its contribution to defense against infection: the case of pulmonary pathogens.

Authors:  Hany Sahly; Yona Keisari; Erika Crouch; Nathan Sharon; Itzhak Ofek
Journal:  Infect Immun       Date:  2007-12-17       Impact factor: 3.441

5.  Vaccination against Klebsiella aerogenes.

Authors:  E A Roe; R J Jones
Journal:  J Hyg (Lond)       Date:  1984-10

6.  Purification and vaccine potential of Klebsiella capsular polysaccharides.

Authors:  S J Cryz; E Fürer; R Germanier
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

7.  Protection against fatal Klebsiella pneumoniae burn wound sepsis by passive transfer of anticapsular polysaccharide.

Authors:  S J Cryz; E Fürer; R Germanier
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

8.  Production of an extracellular toxic complex by various strains of Klebsiella pneumoniae.

Authors:  D C Straus
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

9.  Immunization against fatal experimental Klebsiella pneumoniae pneumonia.

Authors:  S J Cryz; E Fürer; R Germanier
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

10.  Genetic exchange of determinants for capsular polysaccharide biosynthesis between Klebsiella pneumoniae strains expressing serotypes K2 and K21a.

Authors:  I Ofek; K Kabha; A Athamna; G Frankel; D J Wozniak; D L Hasty; D E Ohman
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.